Post the above allotment, the shareholding percentage of Glenmark in Glenmark Life Sciences has reduced from 100% to 82.84%.
Read Full Story at source (may require registration)
- Stick to your SIPs; not the time to raise allocation to equities: Vetri Subramaniam - September 28, 2021
- European, U.K. Equities Have Good Value: Credit Suisse - September 28, 2021
- Equities trade mixed after similar US session - September 28, 2021